Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

15
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
15
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

524
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conduction system pacing in TAVR patients requiring permanent pacemaker implantation.

Heart rhythm·2026
Same author

Fixed Drug Eruption Inversus Associated With Meloxicam.

American journal of therapeutics·2026
Same author

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Multiple Drug Hypersensitivity Confirmed by Skin Testing.

Hospital pharmacy·2026
Same author

A novel method for rapid determination of risperidone in human plasma using Reversed-Phase Liquid Chromatography with Ultra-Violet detection.

La Tunisie medicale·2026
Same author

Early perforation after attempted conduction system pacing: Lessons from the electrocardiogram.

HeartRhythm case reports·2026
Same author

Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Induced by Abiraterone: Evidence From a Positive Rechallenge.

American journal of therapeutics·2026

Related Experiment Video

Updated: Apr 26, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.1K

Drug-induced hyperkalemia.

Chaker Ben Salem1, Atef Badreddine, Neila Fathallah

  • 1Department of Clinical Pharmacology, Faculty of Medicine of Sousse, Farhat Hached University Hospital, Avenue Mohamed Karoui, 4002, Sousse, Tunisia, bensalem.c@gmail.com.

Drug Safety
|July 23, 2014
PubMed
Summary
This summary is machine-generated.

Drug-induced hyperkalemia, a common condition, can be life-threatening. Awareness and monitoring of medications affecting potassium levels are crucial for prevention and management.

More Related Videos

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
07:42

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

Published on: October 18, 2018

7.8K
Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

11.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.1K
Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
07:42

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

Published on: October 18, 2018

7.8K
Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

11.9K

Area of Science:

  • Nephrology
  • Clinical Pharmacology
  • Internal Medicine

Background:

  • Hyperkalemia, defined as serum potassium >5.0 mmol/L, is frequently caused by medications.
  • Drug-induced hyperkalemia presents a significant clinical challenge, ranging from asymptomatic to life-threatening.
  • Understanding drug mechanisms is vital for managing elevated potassium levels.

Purpose of the Study:

  • To review the mechanisms by which drugs induce hyperkalemia.
  • To highlight the importance of drug awareness, monitoring, and prevention strategies.
  • To emphasize the clinical significance of drug-induced hyperkalemia.

Main Methods:

  • Review of literature on drug-induced hyperkalemia.
  • Categorization of drugs based on their mechanisms of action on potassium homeostasis.
  • Analysis of clinical implications and management strategies.

Main Results:

  • Drugs cause hyperkalemia by altering transcellular potassium shifts, impairing renal excretion, or increasing potassium supply.
  • Inhibition of the renin-angiotensin-aldosterone system is a primary mechanism for drug-induced hyperkalemia.
  • Key drug classes include ACE inhibitors, ARBs, NSAIDs, diuretics, and potassium supplements.

Conclusions:

  • Increased awareness of causative agents and proactive monitoring are essential to reduce morbidity and mortality.
  • Effective management of drug-induced hyperkalemia requires a thorough understanding of pharmacological mechanisms.
  • Preventive strategies and vigilant patient monitoring are critical for patient safety.